JCC AGM 2024 takes place at Novartis in Basel

The Annual General Meeting 2024 took place at Novartis Corporate Headquarters in Basel, Switzerland on March 19, 2024. We were delighted to welcome our members at one of the highpoints of the annual program. Marcel Pawlicek, JCC President and Dorit Sallis, JCC Managing Director presented the annual report for 2023 and plans for 2024. Eric Mercanton, Fidexaudit, who audits the finances gave JCC a clean bill of financial health.

Two new board members – Leyla Baghirzade, Founder and CEO, Swiss Alternative Financing, Geneva and Murat Seitnepesov, President, Greater Caspian Region Association; Chairman, Integral Group were voted in by the general assembly. Following the administrative part of the program, SwetaGhilani, Head, Europe Central Cluster, Novartis gave a fascinating presentation about experiences and best practices of working in emerging markets. Members enjoyed networking at the reception and then the visit to the Novartis Pavilion with its healthcare exhibition. A big thank you to Wojciech Nowak, Group Senior Director, Global Governmental and Public Affairs, Novartis and JCC board member for making it happen.